Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial
ISSN: 1464-410X, 1464-4096
Any de publicació: 2020
Volum: 125
Número: 2
Pàgines: 215-225
Tipus: Article